Compare NSPR & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSPR | XPL |
|---|---|---|
| Founded | 2005 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.1M | 74.8M |
| IPO Year | 2009 | 2000 |
| Metric | NSPR | XPL |
|---|---|---|
| Price | $0.74 | $0.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $4.00 | $1.20 |
| AVG Volume (30 Days) | 156.2K | ★ 248.7K |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.86 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,310,000.00 | N/A |
| Revenue This Year | $57.98 | N/A |
| Revenue Next Year | $95.41 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $0.54 |
| 52 Week High | $2.93 | $0.98 |
| Indicator | NSPR | XPL |
|---|---|---|
| Relative Strength Index (RSI) | 29.27 | 44.62 |
| Support Level | N/A | $0.68 |
| Resistance Level | $1.04 | $0.81 |
| Average True Range (ATR) | 0.09 | 0.03 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 12.66 | 38.27 |
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Solitario Resources Corp is an exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. Its core mineral property assets are: the Florida Canyon zinc project in Peru, the Lik zinc project in Alaska, and the Golden Crest project in South Dakota. Additionally, Solitario holds an interest in the Chambara project in Peru and also has two early-stage projects, the Cat Creek project and the Bright Angel project in Colorado. The company is conducting mineral exploration on its Golden Crest project, the Cat Creek project, and the Bright Angel project on its own.